Skip to Content

Gablofen Approval History

FDA Approved: Yes (First approved November 19, 2010)
Brand name: Gablofen
Generic name: baclofen
Dosage form: Injection
Company: CNS Therapeutics
Treatment for: Cerebral Spasticity, Chronic Spasticity

Gablofen (baclofen) is a gamma-aminobutyric acid (GABA) ergic agonist indicated for use in the management of severe spasticity.

Development History and FDA Approval Process for Gablofen

DateArticle
Nov 23, 2010Approval FDA Approves Movement Disorder Drug from CNS Therapeutics: Gablofen (Baclofen Injection) for the Treatment of Severe Spasticity

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide